MedPath

Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patients

Not Applicable
Conditions
Genotype 1 infected chronic liver diseases
Registration Number
JPRN-UMIN000019400
Lead Sponsor
Osaka City University and affiliated hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnant woman Decompensated cirrhosis Hepatocellular carcinoma Renal impairement (eGFR<30ml/min/1.73m2) Doctors judge as inappropriate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sustained viral response
Secondary Outcome Measures
NameTimeMethod
Suppression of hepatocarcinogenesis
© Copyright 2025. All Rights Reserved by MedPath